港股通创新药ETF工银获融资买入0.93亿元，近三日累计买入2.83亿元

Core Viewpoint - The article highlights the recent trading activity of the Hong Kong Stock Connect Innovative Drug ETF, indicating a positive trend in financing buy-ins and net purchases over the last three trading days [1]. Group 1: Financing Activity - On August 7, the Hong Kong Stock Connect Innovative Drug ETF received a financing buy-in amount of 0.93 billion yuan, ranking 425th in the two markets [1]. - The financing repayment amount on the same day was 0.83 billion yuan, resulting in a net buy of 9.5247 million yuan [1]. - Over the last three trading days (August 5-7), the ETF received financing buy-ins of 0.66 billion yuan, 1.24 billion yuan, and 0.93 billion yuan respectively [1]. Group 2: Short Selling Activity - On August 7, the ETF had no short selling activity, with 0.00 thousand shares sold and a net sell of 0.00 thousand shares [1].